Testosterone Pellet 200 mg Recalled for Glass Particulate Matter
BSO LLC is recalling Testosterone Pellet 200 mg compounded drug vials nationwide because glass particles were found in the pellets intended for subcutaneous injection.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a drug product with a serious hazard—glass particles in an injectable drug—that could cause significant injury. Although no illnesses or injuries are explicitly reported in the source text, the risk of harm from glass in a subcutaneously injected pellet is substantial and meets the Severe (Class II) threshold.
Plain-English summary
BSO LLC is recalling Testosterone Pellet 200 mg (Blunt) compounded drug vials due to the presence of glass particles in the pellet vials. This product is a compounded drug intended for subcutaneous use and is restricted to prescription or office use only.
The recall affects 1,964 vials distributed nationwide in the USA. The affected lots are Lot 20250129@1 (expiration 1/17/2026) and Lot 20250218@4 (expiration 1/25/2026). The product is manufactured by BSO LLC, located at 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01.
Patients and healthcare providers who have this product should stop using it immediately and consult their prescribing physician for guidance on appropriate treatment options.
The recalled product
- Product
- TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01
- Manufacturer
- BSO LLC
- Category
- Drug — Compounded Injectable
- Hazard
- glass-particulate
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot 20250129@1
- exp 1/17/2026
- Lot 20250218@4
- exp 1/25/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22